Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease

Juey Jen Hwang, Peiliang Kuan, Shen Chang Lin, Wei Jan Chen, Meng Huan Lei, Yu Lin Ko, Jun Jack Cheng, Jiunn Lee Lin, Jin Jer Chen, Wen Pin Lien

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Systemic arterial embolization imparts a significant risk of serious complications throughout the lives of patients with rheumatic heart disease. Left atrial (LA) thrombi have been thought to be the major source of emboli. A transesophageal echocardiography (TEE) study of 260 consecutive patients with rheumatic mitral valve disease was performed during a period of 24 months, with particular reference to understanding the association between LA thrombi and embolic complications. Of these patients, 155 had predominant mitral stenosis, 24 had significant mitral regurgitation, and the remaining 81 with xenograft mitral valve replacement developed valvular dysfunction (25 resulted in predominant mitral stenosis and 56 in significant mitral regurgitation). LA thrombi were detected in 38 patients (group A) and absent in 222 (group B). Group A patients had a higher frequency of recent (≤1 week before TEE study) and remote (>1 week before) embolization than did group B patients (recent: 26.3 vs 5.4% [p < 0.001]; remote: 18.4 vs 5.0% [p < 0.01]). The frequency of atrial fibrillation was also greater in group A patients (100 vs 74.3%; p < 0.001). The exclusion of patients with significant mitral regurgitation and sinus rhythm had no effect on the association between LA thrombi and evidence of previous embolization. It is concluded that TEE is a convenient diagnostic modality that can be used to identify a subset of patients with rheumatic mitral valve disease at high risk for systemic embolization. Consequently, preventive anticoagulation for possible embolic complications should be more vigorously adhered to in patients with rheumatic mitral valve disease and LA thrombi.

Original languageEnglish
Pages (from-to)769-773
Number of pages5
JournalThe American Journal of Cardiology
Volume70
Issue number7
DOIs
Publication statusPublished - Sep 15 1992
Externally publishedYes

Fingerprint

Transesophageal Echocardiography
Mitral Valve
Thrombosis
Mitral Valve Insufficiency
Mitral Valve Stenosis
Rheumatic Heart Disease
Embolism
Heterografts
Atrial Fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease. / Hwang, Juey Jen; Kuan, Peiliang; Lin, Shen Chang; Chen, Wei Jan; Lei, Meng Huan; Ko, Yu Lin; Cheng, Jun Jack; Lin, Jiunn Lee; Chen, Jin Jer; Lien, Wen Pin.

In: The American Journal of Cardiology, Vol. 70, No. 7, 15.09.1992, p. 769-773.

Research output: Contribution to journalArticle

Hwang, Juey Jen ; Kuan, Peiliang ; Lin, Shen Chang ; Chen, Wei Jan ; Lei, Meng Huan ; Ko, Yu Lin ; Cheng, Jun Jack ; Lin, Jiunn Lee ; Chen, Jin Jer ; Lien, Wen Pin. / Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease. In: The American Journal of Cardiology. 1992 ; Vol. 70, No. 7. pp. 769-773.
@article{09cca0b94b8b492688821a41d8e9321a,
title = "Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease",
abstract = "Systemic arterial embolization imparts a significant risk of serious complications throughout the lives of patients with rheumatic heart disease. Left atrial (LA) thrombi have been thought to be the major source of emboli. A transesophageal echocardiography (TEE) study of 260 consecutive patients with rheumatic mitral valve disease was performed during a period of 24 months, with particular reference to understanding the association between LA thrombi and embolic complications. Of these patients, 155 had predominant mitral stenosis, 24 had significant mitral regurgitation, and the remaining 81 with xenograft mitral valve replacement developed valvular dysfunction (25 resulted in predominant mitral stenosis and 56 in significant mitral regurgitation). LA thrombi were detected in 38 patients (group A) and absent in 222 (group B). Group A patients had a higher frequency of recent (≤1 week before TEE study) and remote (>1 week before) embolization than did group B patients (recent: 26.3 vs 5.4{\%} [p < 0.001]; remote: 18.4 vs 5.0{\%} [p < 0.01]). The frequency of atrial fibrillation was also greater in group A patients (100 vs 74.3{\%}; p < 0.001). The exclusion of patients with significant mitral regurgitation and sinus rhythm had no effect on the association between LA thrombi and evidence of previous embolization. It is concluded that TEE is a convenient diagnostic modality that can be used to identify a subset of patients with rheumatic mitral valve disease at high risk for systemic embolization. Consequently, preventive anticoagulation for possible embolic complications should be more vigorously adhered to in patients with rheumatic mitral valve disease and LA thrombi.",
author = "Hwang, {Juey Jen} and Peiliang Kuan and Lin, {Shen Chang} and Chen, {Wei Jan} and Lei, {Meng Huan} and Ko, {Yu Lin} and Cheng, {Jun Jack} and Lin, {Jiunn Lee} and Chen, {Jin Jer} and Lien, {Wen Pin}",
year = "1992",
month = "9",
day = "15",
doi = "10.1016/0002-9149(92)90557-F",
language = "English",
volume = "70",
pages = "769--773",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease

AU - Hwang, Juey Jen

AU - Kuan, Peiliang

AU - Lin, Shen Chang

AU - Chen, Wei Jan

AU - Lei, Meng Huan

AU - Ko, Yu Lin

AU - Cheng, Jun Jack

AU - Lin, Jiunn Lee

AU - Chen, Jin Jer

AU - Lien, Wen Pin

PY - 1992/9/15

Y1 - 1992/9/15

N2 - Systemic arterial embolization imparts a significant risk of serious complications throughout the lives of patients with rheumatic heart disease. Left atrial (LA) thrombi have been thought to be the major source of emboli. A transesophageal echocardiography (TEE) study of 260 consecutive patients with rheumatic mitral valve disease was performed during a period of 24 months, with particular reference to understanding the association between LA thrombi and embolic complications. Of these patients, 155 had predominant mitral stenosis, 24 had significant mitral regurgitation, and the remaining 81 with xenograft mitral valve replacement developed valvular dysfunction (25 resulted in predominant mitral stenosis and 56 in significant mitral regurgitation). LA thrombi were detected in 38 patients (group A) and absent in 222 (group B). Group A patients had a higher frequency of recent (≤1 week before TEE study) and remote (>1 week before) embolization than did group B patients (recent: 26.3 vs 5.4% [p < 0.001]; remote: 18.4 vs 5.0% [p < 0.01]). The frequency of atrial fibrillation was also greater in group A patients (100 vs 74.3%; p < 0.001). The exclusion of patients with significant mitral regurgitation and sinus rhythm had no effect on the association between LA thrombi and evidence of previous embolization. It is concluded that TEE is a convenient diagnostic modality that can be used to identify a subset of patients with rheumatic mitral valve disease at high risk for systemic embolization. Consequently, preventive anticoagulation for possible embolic complications should be more vigorously adhered to in patients with rheumatic mitral valve disease and LA thrombi.

AB - Systemic arterial embolization imparts a significant risk of serious complications throughout the lives of patients with rheumatic heart disease. Left atrial (LA) thrombi have been thought to be the major source of emboli. A transesophageal echocardiography (TEE) study of 260 consecutive patients with rheumatic mitral valve disease was performed during a period of 24 months, with particular reference to understanding the association between LA thrombi and embolic complications. Of these patients, 155 had predominant mitral stenosis, 24 had significant mitral regurgitation, and the remaining 81 with xenograft mitral valve replacement developed valvular dysfunction (25 resulted in predominant mitral stenosis and 56 in significant mitral regurgitation). LA thrombi were detected in 38 patients (group A) and absent in 222 (group B). Group A patients had a higher frequency of recent (≤1 week before TEE study) and remote (>1 week before) embolization than did group B patients (recent: 26.3 vs 5.4% [p < 0.001]; remote: 18.4 vs 5.0% [p < 0.01]). The frequency of atrial fibrillation was also greater in group A patients (100 vs 74.3%; p < 0.001). The exclusion of patients with significant mitral regurgitation and sinus rhythm had no effect on the association between LA thrombi and evidence of previous embolization. It is concluded that TEE is a convenient diagnostic modality that can be used to identify a subset of patients with rheumatic mitral valve disease at high risk for systemic embolization. Consequently, preventive anticoagulation for possible embolic complications should be more vigorously adhered to in patients with rheumatic mitral valve disease and LA thrombi.

UR - http://www.scopus.com/inward/record.url?scp=0026764910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026764910&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(92)90557-F

DO - 10.1016/0002-9149(92)90557-F

M3 - Article

C2 - 1519528

AN - SCOPUS:0026764910

VL - 70

SP - 769

EP - 773

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 7

ER -